CARCINOMA IN SITU OF URINARY BLADDER

Clinical trials for CARCINOMA IN SITU OF URINARY BLADDER explained in plain language.

Never miss a new study

Get alerted when new CARCINOMA IN SITU OF URINARY BLADDER trials appear

Sign up with your email to follow new studies for CARCINOMA IN SITU OF URINARY BLADDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New bladder cancer drug shows promise in early trial

Disease control Recruiting now

This study tests a new drug called MK-3120 for high-risk non-muscle invasive bladder cancer. After standard tumor removal, 45 participants will receive the drug directly into the bladder. The main goals are to check safety and how well people tolerate it, while also looking at tu…

Matched conditions: CARCINOMA IN SITU OF URINARY BLADDER

Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

CARCINOMA IN SITU OF URINARY BLADDER

Get alerted when new CARCINOMA IN SITU OF URINARY BLADDER trials appear

New bladder cancer drug shows promise in early trial